Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Aug 19, 2009

Premium

Christian Henry has been named vice president of corporate development at Illumina, the company said last week.

In this newly created position, Henry will be responsible for all activities related to corporate and business development, strategic planning, and mergers and acquisitions, Illumina said.

Henry has served as Illumina's chief financial officer since 2005. Before that he held positions at Tickets.com and Affymetrix. The San Diego company said it is now searching for a new CFO.


Several Nanogen executives resigned earlier this month, after the firm sold its assets to Elitech for $25.7 million. The resignations were authorized by the United States Bankruptcy Court for the District of Delaware.

The resignations included Chairman Howard Birndorf, who resigned as CEO last month, and board members David Schreiber, Robert Whalen, Stelio Papadopoulos, and Heiner Dreismann.

In addition, Graham Lidgard resigned as senior vice president of R&D, while David Ludvigson, who served as the president and chief operating officer of the company prior to the issuance of the court's order, was appointed to serve as the president and secretary of Nanogen. Nicholas Venuto, who served as chief financial officer of the firm prior to the order, was re-appointed CFO, according to the firm's SEC filing.


Francis Collins was unanimously confirmed by the US Senate to be the new director of the National Institutes of Health earlier this month.

He becomes the 16th director of NIH.

Collins was director of the National Human Genome Research Institute at NIH from 1993 to 2008, a tenure highlighted by the success of the Human Genome Project, which provided a genomic blueprint of human beings. Before joining NIH, he was on the faculty of the University of Michigan where he was a Howard Hughes Medical Institute investigator.

He is a member of the Institute of Medicine and the National Academy of Sciences. In 2007, he was awarded the Presidential Medal of Freedom.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.